SCHEMBL18039017

SCHEMBL18039017

O=C(Cn1cc(S(=O)(=O)N2CCCC2)ccc1=O)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ GAA P10253 3/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ IKBKB O14920 1/20 0.45
▸ CHUK O15111 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18038989 0.90 L3MBTL1 (0.56) POLBALDH1A1GAACYP1A2CYP2D6
SCHEMBL18038954 0.90 L3MBTL1 (0.56) POLBALDH1A1GAACYP1A2CYP2D6
SCHEMBL18038959 0.90 L3MBTL1 (0.56) POLBALDH1A1GAACYP1A2CYP2D6
SCHEMBL18038956 0.90 ALDH1A1 (0.48) POLBALDH1A1MAPTGAACYP1A2
SCHEMBL18038949 0.89 GAA (0.50) POLBALDH1A1MAPTGAAMEN1
SCHEMBL18038968 0.89 PKM (0.56) POLBALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL18038966 0.88 HTT (0.52) POLBALDH1A1MAPTGAACYP1A2
SCHEMBL18038995 0.88 ALDH1A1 (0.49) POLBALDH1A1MAPTGAATP53
SCHEMBL18038982 0.87 HTT (0.52) POLBALDH1A1GAACYP1A2CYP2D6
SCHEMBL18038953 0.87 L3MBTL1 (0.53) POLBALDH1A1GAACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11311523-B2 Pyridinone compound and use thereof KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2022-04-26 — — US disclosed
EP-3692992-A1 METHOD OF SCREENING DOCK1-SELECTIVE INHIBITORS FOR CANCER TREATMENT Kyushu University National University Corporation (JP) 2020-08-12 — — EP disclosed
EP-3263133-B1 PYRIDINONE COMPOUND AND USE THEREOF UNIV KYUSHU NAT UNIV CORP (JP) 2020-04-01 — — EP disclosed
US-20200061039-A1 PYRIDINONE COMPOUND AND USE THEREOF KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2020-02-27 — — US disclosed
US-10406141-B2 Pyridinone compound and use thereof KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2019-09-10 — — US disclosed
US-20180028515-A1 PYRIDINONE COMPOUND AND USE THEREOF KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2018-02-01 — — US disclosed
EP-3263133-A1 PYRIDINONE COMPOUND AND USE THEREOF Kyushu University, National University Corporation (JP) 2018-01-03 — — EP disclosed
WO-2016136985-A1 PYRIDINONE COMPOUND AND USE THEREOF 国立大学法人九州大学 2016-09-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180028515-A1 PYRIDINONE COMPOUND AND USE THEREOF DOCK5, DOCK2, CIB1 POLB 3980/4885ALDH1A1 52/4885MAPT 4204/4885
US-20200061039-A1 PYRIDINONE COMPOUND AND USE THEREOF DOCK5, DOCK2, CIB1 POLB 3993/4885ALDH1A1 49/4885MAPT 4226/4885
US-10406141-B2 Pyridinone compound and use thereof DOCK5, DOCK2, CIB1 POLB 3980/4885ALDH1A1 52/4885MAPT 4204/4885
US-11311523-B2 Pyridinone compound and use thereof DOCK5, DOCK2, CIB1 POLB 3993/4885ALDH1A1 49/4885MAPT 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback